H

Hangzhou DAC Biotech Co., Ltd.

250 employees

Hangzhou DAC Biotech Co., Ltd focuses on developing conjugate of monoclonal antibody and small molecular cytotoxic drugs.

Basic info

Industry

research services

Sectors

Biotechnology
Health Care
Medical

Date founded

2012

Funding rounds raised

Total raised

$155M

from 5 investors over 5 rounds

H

Hangzhou DAC Biotech Co., Ltd. raised $155M on May 12, 2021

Investors: CITIC Private Equity Funds Management and CITIC Securities Company Limited

H

Hangzhou DAC Biotech Co., Ltd. raised $6.3M on November 27, 2015

Investors: 毅达资本, 浙江科发资本管理有限公司 and Betta Pharmaceuticals Co., Ltd.

FAQ